Evidence map›Paper›PMID 34088321›Full record

ArticleDiagnostic pathology2021

Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.

Ziyao Wang, Shoichi Kimura, Hiromi Iwasaki, Ken Takase, Yumi Oshiro, Ayako Gamachi, Kosuke Makihara, Masao Ogata, Tsutomu Daa, Seiya Momosaki and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostic pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Ziyao WangGraduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Shoichi KimuraGraduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Hiromi IwasakiDepartments of Hematology, Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 8108563, Japan.
Ken TakaseDepartments of Hematology, Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 8108563, Japan.
Yumi OshiroDepartment of Pathology, Matsuyama Red Cross Hospital, 1 Bunkyo-cho, Matsuyama, 7910000, Japan.
Ayako GamachiDepartment of Pathology, Almeida Memorial Hospital, 1509-2. Oita, Miyazaki, 8701195, Japan.
Kosuke MakiharaDepartment of Pathology, Kyushu Rosai Hospital, 1-1, Sonekita, Kokura South Ward, Kitakyushu, 800-0296, Japan.
Masao OgataDepartments of Hematology, Faculty of Medicine, Oita University, Idaigaoka, Hazama-machi, Yufushi, Oita, 8795593, Japan.
Tsutomu DaaDepartments of Pathology, Faculty of Medicine, Oita University, Idaigaoka, Hazama-machi, Yufushi, Oita, 8795593, Japan.
Seiya MomosakiDepartments of Pathology, Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 8108563, Japan.
Yasushi TakamatsuDepartments of Internal Medicine, Division of Medical Oncology, Hematology and Infectious Disease, Faculty of Medicine, and Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Morishige TakeshitaGraduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan. m-take@adm.fukuoka-u.ac.jp.
Fukuoka University · JPNational Kyushu Medical Center · JPOita University · JPAlmeida Memorial Hospital · JPKyushu Rosai Hospital · JPMatsuyama Red Cross Hospital · JP

Funding

Grant-in-Aid for Scientific Research (No. 17K08732) from the Ministry of Education, Science and Culture of Japan No. 17K08732)
6 · The paper itself

Abstract

backgroundSystemic Epstein-Barr virus

methodsWe investigated clinicopathological features in 16 patients of various ages with systemic EBV

resultsEight younger patients and four of eight older adults had sEBV

conclusionsEBV

Indexed as

Cell ProliferationAdultAgedAged, 80 and overAntineoplastic AgentsBiomarkers, TumorCD8-Positive T-LymphocytesCell Transformation, ViralChild, PreschoolEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHost-Pathogen InteractionsHumansLymphohistiocytosis, HemophagocyticLymphoma, T-CellAntineoplastic AgentsBiomarkers, TumorCD8+ T-cell lymphomaEpstein-Barr virusHemophagocytic lymphohistiocytosisSystemic EBV+ T-cell lymphoma of childhood

Identifiers

PMID34088321
PMCPMC8176609
OpenAlexW3164033312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.